Next Article in Journal
Vertebral Body Tethering: Indications, Surgical Technique, and a Systematic Review of Published Results
Next Article in Special Issue
Predicting, Recognizing, and Treating Right Heart Failure in Patients Undergoing Durable LVAD Therapy
Previous Article in Journal
The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis
Previous Article in Special Issue
The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Left Ventricular Assist Devices: A Primer for the Non-Mechanical Circulatory Support Provider

by
Gregory S. Troutman
1 and
Michael V. Genuardi
2,*
1
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
2
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(9), 2575; https://doi.org/10.3390/jcm11092575
Submission received: 6 April 2022 / Revised: 25 April 2022 / Accepted: 30 April 2022 / Published: 4 May 2022

Abstract

Survival after implant of a left ventricular assist device (LVAD) continues to improve for patients with end-stage heart failure. Meanwhile, more patients are implanted with a destination therapy, rather than bridge-to-transplant, indication, meaning the population of patients living long-term on LVADs will continue to grow. Non-LVAD healthcare providers will encounter such patients in their scope of practice, and familiarity and comfort with the physiology and operation of these devices and common problems is essential. This review article describes the history, development, and operation of the modern LVAD. Common LVAD-related complications such as bleeding, infection, stroke, and right heart failure are reviewed and an approach to the patient with an LVAD is suggested. Nominal operating parameters and device response to various physiologic conditions, including hypo- and hypervolemia, hypertension, and device failure, are reviewed.
Keywords: left ventricular assist devices; heart failure with reduced ejection fraction; right heart failure left ventricular assist devices; heart failure with reduced ejection fraction; right heart failure

Share and Cite

MDPI and ACS Style

Troutman, G.S.; Genuardi, M.V. Left Ventricular Assist Devices: A Primer for the Non-Mechanical Circulatory Support Provider. J. Clin. Med. 2022, 11, 2575. https://doi.org/10.3390/jcm11092575

AMA Style

Troutman GS, Genuardi MV. Left Ventricular Assist Devices: A Primer for the Non-Mechanical Circulatory Support Provider. Journal of Clinical Medicine. 2022; 11(9):2575. https://doi.org/10.3390/jcm11092575

Chicago/Turabian Style

Troutman, Gregory S., and Michael V. Genuardi. 2022. "Left Ventricular Assist Devices: A Primer for the Non-Mechanical Circulatory Support Provider" Journal of Clinical Medicine 11, no. 9: 2575. https://doi.org/10.3390/jcm11092575

APA Style

Troutman, G. S., & Genuardi, M. V. (2022). Left Ventricular Assist Devices: A Primer for the Non-Mechanical Circulatory Support Provider. Journal of Clinical Medicine, 11(9), 2575. https://doi.org/10.3390/jcm11092575

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop